Cargando…

Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway

Peroxisome proliferator-activated receptor alpha (PPARα) ligands have been reported to suppress cancer growth. However, the role of PPARα in hepatocarcinogenesis remains unclear. We investigated the functional significance of PPARα in hepatocellular carcinoma (HCC). PPARα-knockout (PPARα(-/-)) mice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ning, Chu, Eagle S. H., Zhang, Jingwan, Li, Xiaoxing, Liang, Qiaoyi, Chen, Jie, Chen, Minhu, Teoh, Narci, Farrell, Geoffrey, Sung, Joseph J.Y., Yu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226686/ https://www.ncbi.nlm.nih.gov/pubmed/25327562

Ejemplares similares

Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1
por: Arfianti, Evi, et al.
Publicado: (2016)

An overview of peroxisome proliferator-induced hepatocarcinogenesis.
por: Rao, M S, et al.
Publicado: (1991)

The Role of NF-κB in PPARα-Mediated Hepatocarcinogenesis
por: Glauert, Howard P., et al.
Publicado: (2008)

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
por: Maeda, Shin
Publicado: (2010)

Clofibrate treatment in pigs: Effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents
por: Luci, Sebastian, et al.
Publicado: (2007)

Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator.
por: Hsieh, L. L., et al.
Publicado: (1991)

Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome – time is of the essence
por: Teoh, Narci, et al.
Publicado: (2020)

Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice
por: Wang, Shanshan, et al.
Publicado: (2021)

Adaptation of peroxisome proliferator-activated receptor alpha to hibernation in bats
por: Han, Yijie, et al.
Publicado: (2015)

Peroxisome Proliferator-Activated Receptor Alpha Target Genes
por: Rakhshandehroo, Maryam, et al.
Publicado: (2010)

Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway
por: Zhang, Cong, et al.
Publicado: (2019)

Accumulation of Linoleic Acid by Altered Peroxisome Proliferator-Activated Receptor-α Signaling Is Associated with Age-Dependent Hepatocarcinogenesis in Ppara Transgenic Mice
por: Zhu, Xiaoyang, et al.
Publicado: (2023)

Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
por: Wang, Yuhong, et al.
Publicado: (2018)

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice
por: Kong, Lingbo, et al.
Publicado: (2011)

Mechanisms Involved in the Enhanced Susceptibility of Senescent Rats to the Hepatocarcinogenic Effect of Peroxisome Proliferators: Role of Peroxisome Proliferator-Activated Receptor alpha (PPAR), Cell Proliferation and Oxidative Stress
por: Youssef, Jihan A., et al.
Publicado: (2001)

Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats.
por: Reddy, J. K., et al.
Publicado: (1979)

Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha
por: Li, Guolin, et al.
Publicado: (2017)

Hepatic Peroxisome Proliferator-Activated Receptor Alpha Dysfunction in Porcine Septic Shock
por: Vandewalle, Jolien, et al.
Publicado: (2022)

Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor
por: Yagai, Tomoki, et al.
Publicado: (2022)

BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness
por: Kaufmann, Benedikt, et al.
Publicado: (2017)

The Matricellular Protein CCN1 Suppresses Hepatocarcinogenesis by Inhibiting Compensatory Proliferation
por: Chen, Chih-Chiun, et al.
Publicado: (2015)

Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-κB into the Nucleus
por: Ogawa, Yuji, et al.
Publicado: (2012)

Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for kupffer cells?
por: Alsarra, Ibrahim A, et al.
Publicado: (2006)

Peroxisome Proliferators: Response
por: Melnick, R
Publicado: (2001)

Perplexing peroxisome proliferators.
por: Citron, M
Publicado: (1995)

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice
por: Nan, Yue-Min, et al.
Publicado: (2013)

Developmental Effects of Perfluorononanoic Acid in the Mouse Are Dependent on Peroxisome Proliferator-Activated Receptor-Alpha
por: Wolf, Cynthia J., et al.
Publicado: (2010)

Activation and Expression of Peroxisome Proliferator-Activated Receptor Alpha Are Associated with Tumorigenesis in Colorectal Carcinoma
por: Morinishi, Tatsuya, et al.
Publicado: (2019)

Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
por: Basso, Paulo José, et al.
Publicado: (2021)

Exploring compounds to be used as cosmetic agents that activate peroxisome proliferator‐activated receptor alpha
por: Tachibana, Keisuke, et al.
Publicado: (2022)

The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice
por: Haczeyni, Fahrettin, et al.
Publicado: (2017)

Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
por: Gehrke, Nadine, et al.
Publicado: (2016)

Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy
por: Deng, Guotao, et al.
Publicado: (2017)

Molecular characterization of hepatocarcinogenesis using mouse models
por: Teoh, Wei Wei, et al.
Publicado: (2015)

Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure
por: Zhang, Li, et al.
Publicado: (2016)

Role of peroxisome proliferator-activated receptor alpha and gamma in antiangiogenic effect of pomegranate peel extract
por: Dana, Nasim, et al.
Publicado: (2016)

Molecular docking of Glyceroneogenesis pathway intermediates with Peroxisome Proliferator- Activated Receptor-Alpha (PPAR-α)
por: Subramani, Parasuraman Aiya, et al.
Publicado: (2013)

Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma
por: Xiao, Yong-bo, et al.
Publicado: (2018)

Peroxisome proliferator-activated receptor alpha is involved in the temperature-induced sex differentiation of a vertebrate
por: Hara, Seiji, et al.
Publicado: (2020)

Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments
por: Engel, Connor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j6cnc8n0tg1qa8dp11sk9fpjf3